Neeraj Agarwal

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Defining biologically directed therapy target signatures in urothelial carcinoma: A transcriptomic framework for precision therapy

  bioRxiv (Cold Spring Harbor Laboratory) · 2026-06-25

• Bacoside-A from Bacopa monnieri (L.) Wettst. in Parkinson’s disease: In Silico and preclinical insights into dopaminergic neuroprotection

  Biomedicine & Pharmacotherapy · 2026-06-23

• Supplementary Table S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

  2026-06-17

• Supplementary Figure S2 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

  2026-06-17

• Supplementary Figure S5 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

  2026-06-17

• Supplementary Figure S4 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

  2026-06-17

• Supplementary Table S1 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

  2026-06-17

• Supplementary Figure S3 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

  2026-06-17

• Supplementary Figure S1 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

  2026-06-17

• Supplementary Figure S6 from CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma

  2026-06-17

• Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association

  Journal of Clinical Oncology · 2026-06-15

• Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association

  Circulation · 2026-06-15

• Supplementary Data1 from Molecular Characterization of <i>KLK2</i> RNA Expression in Prostate Cancer

  2026-06-01

• Serum micronutrient levels in men with prostate carcinoma: An observational study at a tertiary care health facility

  Urologia Journal · 2026-05-29

• Outcomes of immune-checkpoint inhibitor rechallenge in metastatic clear-cell renal cell carcinoma: results from a global real-world evidence study

  ESMO Open · 2026-04-21

• Survival Outcomes Based on Line of Therapy and Treatment Trends With Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer

  JCO oncology advances. · 2026-04-01

• Relapsed/refractory clinically advanced (CA) testicular non-seminomatous germ cell tumors (NSGCT): A genomic landscape study.

  Journal of Clinical Oncology · 2026-03-01

• Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials

  Cancer · 2025-12-20

• Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer

  Nature Communications · 2025-12-17 · 2 citations

• Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer

  Clinical Cancer Research · 2025-12-04 · 1 citations